Trials / Completed
CompletedNCT00092131
Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, 2-Period, Crossover Study to Evaluate the Effects of a Single Dose of Montelukast on Exercise-Induced Bronchospasm
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 15 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exercise-induced bronchospasm), in participants who have a history of worsening asthma after exercise.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Comparator: Montelukast | Montelukast 10 mg tablet administered orally as a single witnessed dose before exercise challenge |
| DRUG | Comparator: Placebo | Placebo tablet administered orally as a single witnessed dose before exercise challenge |
Timeline
- Start date
- 2003-06-01
- Primary completion
- 2003-11-01
- Completion
- 2003-11-01
- First posted
- 2004-09-24
- Last updated
- 2022-02-02
- Results posted
- 2010-06-17
Source: ClinicalTrials.gov record NCT00092131. Inclusion in this directory is not an endorsement.